PREDICTIVE PRECISION MEDICINE PLATFORM
NOTABLE’S PREDICTIVE PRECISION MEDICINE PLATFORM IDENTIFIES AND SELECTS THOSE PATIENTS WHO WILL CLINICALLY RESPOND TO THEIR TREATMENT


NOTABLE’S PREDICTIVE PRECISION MEDICINE PLATFORM IDENTIFIES RESPONDERS WITH 97% ACCURACY*
Notable’s platform accuracy has been demonstrated across multiple hematological malignancies and is expanding to more indications. The utility of the platform ranges across therapeutic modalities from small molecules, biologics, to cell therapies.
*Average response rate across 4 clinical validation trials, data on file.
COMPLEXITY AT SCALE: INTEGRATION OF BIOLOGY, ENGINEERING & DATA
Notable’s platform is driven by automation, software, laboratory science, and data science to capture complexity at scale. Through AI/machine learning loops with countless variations of bio-assay conditions, response bio-measures, and computational algorithms, schedules, we capture the intricacies of cancer bio response and continually optimize PPMP’s precision of predicting response.

MASSIVE DATA REPOSITORY IN HEMATOLOGIC MALIGNANCIES
The high-throughput automated platform has generated a massive data repository in hematologic and other malignancies. With 190 Billion lines of data created across thousands of patient samples and therapeutic compounds, PPMP powers the identification of the most promising therapeutic assets and response prediction with high precision.

TARGET, BOOST AND FAST-TRACK THE MOST COMPELLING CANDIDATE THERAPIES
PPMP identifies the best in-licensing and co-development opportunities to boost their response rates and fast-track their clinical development.